Dr. Algarni discusses Translating Data into Clinical Practice
Dr. Abdulkareem Algarni
Dr. Abdulkareem Algarni, MD Consultant Hematology, KAH/MNGHA, Eastern Region, SA Assistant professor of Hematology/oncology at KSAU-HS, talks about the translating data into clinical practice. Dr. Abdulkareem Algarni initially discusses about CLL case report and indication for initiating treatment. As a continuation for this he explained how to select the first line therapy by analyzing the survival outcomes and comparisons based on IGHV mutation status. Also explained the comparison of PFS between ELEVTE TN, CLL14 and ILLUMINATE trial. Side effects of BTKi discusses by taking ELEVATE RR study and survival outcomes, reported adverse events mentioned. Dr. Abdulkareem Algarni initially considering all these points are added in the case report.
Explore more videos
Critical Evaluation of BTKis in CLL
Dr. George Follows, UK
Evolvement of CLL Management
Dr. Mahmoud Marashi, UAE
CLL Management Inside the Clinic
Dr. Hani Yousif Osman , UAE